Reducing our environmental impact
We recognise that patient and planetary health are closely connected. We are committed to reducing our environmental impact through practical action, focused on conserving energy and minimising waste.
At Pharmanovia, responsibility is part of how we create long-term impact. As a focused innovative specialty pharma company our responsibility priorities span patient health and safety, product quality, ethical governance, employee wellbeing, environmental impact and responsible commercial operations.
Delivering our ESG strategy is a shared responsibility across Pharmanovia and is guided by our values of Care, Transparency and Ownership.
We also expect the same high standards from our business partners, working with organisations that share our commitment to ethical, responsible and sustainable ways of operating. Learn more in our 2024 Sustainability Report below:
We recognise that patient and planetary health are closely connected. We are committed to reducing our environmental impact through practical action, focused on conserving energy and minimising waste.
We know healthier futures depend on a healthier planet. That’s why we are committed to reducing greenhouse gas emissions across our value chain by 2030.
In 2023, our net-zero targets were approved by the Science Based Targets initiative, confirming they are aligned with the latest climate science.
We believe safe, reliable healthcare should be accessible to everyone. Since naming HIPZ as our global charity partner in 2021, we have helped strengthen healthcare infrastructure in Zanzibar and improve access to essential medicines and treatment for underserved communities.
Pharmanovia’s support has helped train healthcare professionals, provide life-saving equipment and deliver critical medicines to patients with the greatest need.
In 2022, we began working with International Health Partners (IHP), a global health NGO that supports people in disaster-hit and vulnerable communities to access vital medicines. During 2025 we provided donations of critical medicines for Zanzibar to support the ongoing cardiovascular care programme there.
Product safety and quality are fundamental to better patient outcomes. Every Pharmanovia employee completes pharmacovigilance training to help recognise and report potential adverse reactions quickly and responsibly.
Engagement de Pharmanovia en matière d’activités d’information promotionnelle en France – Pharmanovia’s commitment to promotional activities in France
Our quality approach: Pharmanovia is strongly committed to a continuous quality improvement process through our Quality Policy and to providing compliant promotional activities on behalf of our clients.
Notre démarche qualité : Pharmanovia s’engage pleinement dans une démarche d’amélioration continue de la qualité, conformément à sa politique qualité, et s’attache à mener des actions promotionnelles conformes pour le compte de ses clients.
Please click here to view Charter document
Veuillez cliquer ici pour consulter la Charte
At Pharmanovia, acting with care means making decisions that protect patients, support customers to uphold the highest ethical standards and to ensure that we operate with integrity at all times. Regular training and clear guidance help our people act with care, transparency and ownership.
We expect the same from our business partners through our Business Partner Code of Conduct. Anyone can raise concerns through our Speak Up Hotline, and every report is investigated promptly.